Ani Pharmaceuticals (ANIP) Shares Outstanding (2010 - 2026)

Ani Pharmaceuticals has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $23.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 6.73% year-over-year to $23.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.8 million (up 6.73% YoY) and the FY2025 annual result came in at $23.1 million, up 7.31% from the prior year.
• Shares Outstanding (Entity) improved to $23.8 million in Q1 2026 per ANIP's latest filing, from $23.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $23.8 million in Q1 2026 and troughed at $17.4 million in Q1 2022.
• A 5-year average of $20.6 million and a median of $21.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) surged 40.08% in 2022, then advanced 3.83% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $17.6 million in 2022, then climbed by 17.5% to $20.7 million in 2023, then increased by 3.89% to $21.5 million in 2024, then increased by 7.31% to $23.1 million in 2025, then gained by 2.97% to $23.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $23.8 million, $23.1 million, and $23.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.